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Abstract
We used a serum-free, highly defined primary hepatocyte culture model to investigate the mechanisms whereby dexamethasone (Dex) and
extracellular matrix (ECM) coordinate cell differentiation and transcriptional responsiveness to the inducer, phenobarbital (PB). Low
nanomolar levels of Dex and dilute concentrations of ECM overlay were essential in the maintenance of normal hepatocyte physiology, as
assessed by cell morphology, LDH release, expression of the hepatic nuclear factors C/EBPa,- h,- g, HNF-1a,- 1 h,- 4 a, and RXRa,
expression of prototypical hepatic marker genes, including albumin and transferrin, and ultimately, cellular capacity to respond to PB. The
loss of hepatocyte integrity produced by deficiency of these components correlated with the activation of several stress signaling pathways
including the MAPK, SAPK/JNK, and c-Jun signaling pathways, with resulting nuclear recruitment of the activated protein-1 (AP-1)
complex. In Dex-deficient cultures, normal cellular function, including the PB induction response, was largely restored in a dose-dependent
manner by reintroduction of nanomolar additions of the hormone, in the presence of ECM. Our results demonstrate critical and cooperative
roles for Dex and ECM in establishing hepatocyte integrity and in the coordination of an array of liver-specific functions. These studies
further establish the PB gene induction response as an exceptionally sensitive indicator of hepatocyte differentiation status.
D 2003 Elsevier Inc. All rights reserved.
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Introduction
The balance between liver differentiation and growth is
determined by the coordinated interaction of a myriad of
extracellular signals in the microenvironment of the liver
cell [1,2]. This interplay, including cell–extracellular matrix
(ECM) [3] and cell–cell interactions [4], function in the
context of a diversity of growth factors and other hormonal
stimuli to determine the course of hepatocyte proliferation,
differentiation, and survival [5]. Although the molecular
mechanisms integrating these diverse signals have not been
entirely elucidated, cell–ECM interactions likely function to
enhance the fidelity of receptor-activated signal transduction
pathways associated with growth factors [6].
Glucocorticoids (GCs) play pivotal roles in determining
the functional integrity of a number of cell types. The
associated biological effects are mediated by the intracellular
glucocorticoid receptor (GR), which upon ligand activation
and nuclear translocation, regulates a diverse collection of
genes through both transcriptional and post-transcriptional
mechanisms [7–9]. GR regulatory mechanisms include di-
rectcross-talkbetweentheGRandothertranscriptionfactors,
notablythe activated protein-1 (AP-1)and NF-nBcomplexes
[10,11]. The ability of GCs to transrepress both of these
factors is likely of fundamental physiological significance,
resulting, for example, in their profound anti-inflammatory
and antineoplastic properties [12,13].G r o w t hf a c t o ra n d
cytokine-mediated stimulation of AP-1 activity may proceed
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vated protein kinase family, including extracellular-regulated
kinase(Erk1/2)MAPK,p38MAPK,andc-JunNH2-terminal
kinase (JNK) [14,15]. Other steroids and retinoids also
mitigatecellularstressasevidencedbytheirpharmacological
actions as anti-inflammatory, immunosuppressive, and anti-
neoplastic agents [16,17]. Recent evidence demonstrates that
GCsinhibitapoptoticeventsinanumberofcelltypesthrough
induction of specific survival pathways, including the acti-
vation of serine/threonine survival kinase (sgk-1) [16,17].
Induction of pharmaceutical and carcinogen-metabolizing
enzymes,suchasthecytochromeP450s,isahallmarkfeature
of cellular defense, with broad toxicological significance
[18,19]. Phenobarbital (PB) is a prototypical hepatic enzyme
inducer, exhibiting pleiotropic effects on liver physiology,
including hypertrophy and altered cell–cell communication
[20]. The PB gene induction response is liver-selective and
appears uniquely sensitive to the cellular microenvironment.
The molecular mechanisms of the response have been char-
acterized in part, with key features including the nuclear
translocation of the constitutive androstane receptor (CAR)
[21], its subsequent partnering with RXRa and interaction of
the nuclear receptor dimer complex with a PB response-
enhancer module (PBREM), a DNA enhancer element pres-
ent upstream of PB inducible genes [22,23].
Previous studies have demonstrated a critical requirement
for both ECM and nanomolar concentrations of Dex in
directing the robustness of in vivo-like xenobiotic respon-
siveness in primary rodent [24–26] and human hepatocytes
[27]. Although it has been reported that Dex exposures
themselves enhance CAR expression levels [27], an alter-
native hypothesis for the potentiative effects of Dex on the
PB induction process is that Dex impinges on a cluster of
additional signaling pathways that act in concert with CAR
to direct the overall expression of the hepatic phenotype.
In the present investigation, we used a well-defined and
serum-free primary rat hepatocyte culture system [24,28] to
investigate the interplay between Dex and ECM as modu-
lators of cell survival, cellular differentiation, and PB
responsiveness. The influence of ECM and Dex on the
hepatic phenotype was profound. Our results demonstrate
critical and cooperative roles for Dex and ECM in the
promotion of hepatocyte integrity, in the coordination of
an array of liver-specific functions, and establish the PB
gene induction response as an exceptionally sensitive indi-
cator of hepatocyte differentiation status.
Materials and methods
Cell culture materials and chemicals
All cell culture media and Trizolk were purchased from
Life Technologies (Grand Island, NY). Matrigelk,I T S +
[insulin, transferrin, selenium, bovine serum albumin [BSA]
and linoleic acid], and Nu-Serumk were obtained from
Becton Dickinson (Bedford, MA). Transferrin, selenium,
and BSA–linoleic acid were obtained from Sigma (St.
Louis, MO). Collagenase (Type 1) was purchased from
Worthington Biochemical Corporation (Lakewood, NJ).
Fig. 1. Effect of ECM overlay and Dex concentration on PB-inducible and liver-specific gene expression. Primary rat hepatocytes were cultured for a total of 96
h under the stated Dex concentrations (nM) and in the absence (Panels A, B) or presence (Panels C, D) of an ECM overlay. In the PB-treated dishes, PB (500
AM) was added after 72 h in culture and maintained for an additional 24 h. Total RNAwas isolated and evaluated by slot-blot analysis for the expression levels
of PB-inducible and liver-specific genes as described under Materials and methods. Ribosomal 18S and GAPDH RNA hybridization levels were used as
normalization standards.
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Biocoat dishes were obtained from Becton Dickinson
(Franklin Lakes, NJ). Dexamethasone (Dex; 9afluoro-
16amethyl-11h,17a,21-trihydroxy-1,4-pregnadiene-3,20-
dione), and bovine insulin were obtained from Sigma. The
lactate dehydrogenase (LDH)-based cell cytotoxicity kit was
obtained from Promega (Madison, WI).
Isolation and culture of hepatocytes
Rat hepatocytes were isolated from adult Sprague–Daw-
ley male rats (Simenson Labs, Gilroy, CA) by a two-step
collagenase perfusion in situ and cultured with modification
[25,28] of a protocol described previously [24]. Briefly,
cells were plated on tissue culture-treated plastic dishes in
William’s E medium in the presence of 10% Nu-Serumk
(no serum was added to cells cultured on collagen-coated
dishes) and 100 nM dexamethasone (Dex). Cells were
allowed to attach for 3 h before switching to a serum-free
medium (William’s E, 10 nM insulin, 6.25 Ag/ml transferrin,
6.25 ng/ml selenium, 1.25 mg/ml BSA, 5.35 Ag/ml linoleic
acid, and variable concentrations of Dex-1, 5, 25, or 1000
nM). Subsequently, cells were cultured in the latter formu-
lation with daily medium changes. In other experiments,
cells were cultured in the serum-free formulation with Dex
additions occurring at varying time points (4, 24, 48, or 72
h after plating).
Matrigelk overlay
A dilute concentration (233 Ag/ml, final concentration) of
ECM (Matrigelk) was added to respective plates as an
overlay [24] following the first medium change, 4 h after
plating.
Phenobarbital treatments
Typically, cells were cultured for 72 h before the addition
of PB (500 AM). Cells were then maintained in PB for 24
h at which point cells were harvested for endpoint analyses.
Representative data are shown from multiple experiments
performed independently with several different hepatocyte
preparations.
RNA analysis
Total RNA was isolated using Trizolk as described
previously [28] and analyzed by slot-blot hybridization
[25]. The antisense exon 3 DNA oligonucleotide probe,
MR/CAR-rp [5V -GGCCTTGCTGACCTCACA-3V ], was
used as a hybridization probe for rat CAR RNAs.
cDNA hybridizations
A cDNA probe specific for rat RXRa was an EcoRI–
XhoI fragment of a rat RXRa cDNA obtained from a clone
derived from a Sprague–Dawley rat liver Matchmaker
cDNA library (Clontech, Palo Alto, CA). cDNA probes
specific for rat GST-Pi and mEH were used as previously
reported [25,29], while a cDNA probe for rat GAPDH was
obtained from Sigma. PCR products were radiolabeled
using the DECAprimek DNA labeling kit (>3000 Ci
mmol
 1, New England Nuclear/Dupont, Boston, MA).
Hybridization was performed essentially as described [25],
except conducted at 60jC in the absence of formamide.
Determination of LDH release
Levels of LDH were determined in triplicate in the
extracellular medium, spectrophotometrically, as per manu-
facturer’s instructions (Promega), as reported [30].
Analysis of PKB, SAPK/JNK, p42/44 MAPK, and c-Jun
phosphorylation status
Primary hepatocytes were cultured in the presence or
absence of varying concentrations of Dex and ECM overlay
for 96 h before cell harvest and analysis of extracts by SDS-
PAGE [31]. Following manufacturer’s blotting instructions,
Fig. 2. Time course of Dex rescue on the expression levels of PB-inducible
and liver-specific gene expression in primary rat hepatocytes. Primary rat
hepatocytes were cultured for a total of 96 h in the presence of an ECM
overlay. At the indicated time points (4, 24, 48, or 72 h post-plating), Dex
(25 nM) was added to the medium and the cells were continued in culture
until the 96 h time point. The ‘‘’’ designation indicates that no Dex was
added to the cultures. Panel A: PB-induction responses; Panel B: Live-
specific marker genes.
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ies that recognize phosphorylated PKB (Akt), SAPK/JNK
and p42/44 MAPK, and c-Jun, respectively (New England
Biolabs, Beverly, MA). The membranes were then incubat-
ed with a goat anti-rabbit horseradish peroxidase-conjugated
secondary antibody (1:2000 dilution). Treatments were
normalized in parallel by assessment of protein loading
using phosphorylation-independent antibodies against Akt
(a-Akt), SAPK/JNK, and p42/44 MAPK. The ECL chemi-
luminescence system (Amersham, Piscataway, NJ) was used
to visualize specific immunoreactive proteins.
Electromobility shift assays
Electromobility shift assays (EMSA) were conducted
essentially as previously reported [30], using nuclear
extracts isolated from hepatocytes treated with the various
concentrations of Dex and in the presence or absence of
ECM overlay. Double-stranded consensus oligonucleotides
for activated protein-1 (AP-1) (5V -CGCTTGATGACT-
CAGCCGGAA-3V , Santa Cruz, Santa Cruz, CA), C/EBPa
(5V -TGCAGATTGCGCAATCTGCA-3V , Santa Cruz), HNF-
1a (5V -CCAGTTAATGATTAACCACTGGC-3V , Geneka
Biotechnology, Montreal, Quebec, Canada), HNF-3a (5V -
GCCCATTGTTTGTTTTAAGCC-3V , Geneka), HNF-4 (5V -
GGAAAGGTCCAAAGGGCGCCTTG-3V , Geneka), and
RXRa (5V -AGCTTCAGGTCAGAGGTCAGAGAGCT-3V ,
Santa Cruz) were end-labeled with g
32P ATP using T4
polynucleotide kinase (Amersham). Wild type and mutant
oligonucleotides were used in 80-fold excess to the radio-
labeled probe in competition experiments. Hepatocyte nu-
clear protein was isolated using the NuPer kit (Pierce,
Fig. 3. Effect of ECM overlay and dexamethasone concentration dependency on hepatocyte morphology and viability. Primary rat hepatocytes were cultured
for a total of 96 h under the stated dexamethasone concentrations (nM), in the absence (Panel A) or presence (Panel B) of an ECM overlay. The effect of both
agents on the representative morphology (20 magnification) of primary rat hepatocytes is shown. Arrows identify evidence of perturbed morphology:
condensed cytoplasm and rounded-up cells, attributed to cytotoxicity. The lower right panel shows the relative level of LDH leakage associated with each Dex
concentration. Scale bar = 50 Am.
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was incubated in binding buffer (50 mM Tris–Cl, pH 7.5,
2.5 mM DTT, 2.5 mM EDTA, 250 mM NaCl, 5 mM MgCl2,
and 20% glycerol) for 15 min at RT. The labeled probe
(0.5 ng) (approximately 100,000–200,000 cpm in a 20-
Al reaction volume) was added and incubated for an
additional 15 min at RT. From this reaction mixture, nuclear
protein complexes were resolved on 5% TBE gels (BioRad,
Hercules, CA), dried, and subjected to autoradiography.
Protein concentration was determined with bovine serum
albumin as standard using a commercial kit (BCA protein
assay reagent, Pierce).
In separate analyses, the expression pattern of the re-
spective transcription factors was determined by SDS-PAGE
in the same nuclear extracts as used for EMSA analysis. The
primary antibodies for each family member were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA).
Results
Previous studies have indicated that Dex was an impor-
tant modulator of xenobiotic responsiveness in cultured
primary hepatocytes [25]. To better determine the mecha-
nistic basis of this response, we performed a series of
experiments manipulating Dex concentrations and ECM
exposures in a highly defined hepatocyte culture system
and evaluated the biological impact of these manipulations
on selected cellular endpoints.
The dose dependency of Dex on PB-inducible and liver-
specific gene responses
Typically, cells were cultured for 72 h before challenge
with PB. During the initial 72-h culture period, cells were
maintained in the presence or absence of ECM overlay, and
Fig. 3 (continued).
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induction endpoints, cells were then treated with 500 AM
PB and continued in the presence of the inducer for an
additional 24 h. Total RNA was then isolated and subjected
to expression profiling of various PB-inducible genes and
other liver-selective markers (Fig. 1A). Levels of 18S and
GAPDH RNAwere assessed as standard comparators. In the
absence of ECM overlay, PB treatment resulted in a modest
induction of CYP2B1, but only in the presence of 25 nM
Dex. No induction of either CYP2B2 or 3A1 mRNAs was
evident under the latter conditions, although CYP3A1
induction was evident with 1000 nM Dex. The expression
level of mEH was not altered appreciably by Dex, although
PB appeared to modestly induce mEH in the presence of
higher Dex concentrations. In contrast, the levels of both
CAR and RXRa mRNAs increased in a dose-dependent
manner with Dex addition.
The mRNA levels of the liver-specific markers, albumin,
transthyretin, and transferrin were affected markedly by Dex
additions (Fig. 1B). The expression level of GST-Pi, a gene
typically quiescent in differentiated adult hepatocytes, was
clearly elevated in the presence of V1 nM Dex. Elevating
the Dex concentration resulted in suppression of the aber-
rant GST-Pi response. The mRNA level of the housekeeping
gene, GAPDH, was also reduced in the absence of ECM
overlay, and with limiting Dex conditions.
Interdependency of ECM overlay and Dex on hepatic gene
expression
We further examined the coordination between ECM
and Dex on cellular responses in cultured hepatocytes.
Even low concentrations (e.g., 5 nM) of Dex, in the
presence of an ECM overlay, markedly intensified the
PB-induction response for CYP2B1, 2B2, and 3A1 (Fig.
1C). Optimal PB induction of CYP2B and 3A1 was
obtained in the presence of 25 nM Dex plus ECM overlay.
The highest concentration of Dex tested (1000 nM) in-
Fig. 4. Effect of time course of Dex rescue on hepatocyte morphology and viability. Primary rat hepatocytes were cultured in total for 96 h in the presence of an
ECM overlay. At the indicated time points (4, 24, 48, or 72 h post-plating), Dex (25 nM) was added to the medium and the cells were continued in culture until
the 96-h time point. The delayed effect of Dex addition on the representative morphology (20 magnification) of primary rat hepatocytes is shown. Arrows
identify evidence of perturbed morphology indicated by condensed cytoplasm and rounded cells attributed to cytotoxicity. The lower right panel shows the
relative level of LDH leakage associated with the time course of Dex rescue. Scale bar = 50 Am.
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multaneously inhibiting the CYP2B PB-induction response.
The latter result is consistent with previously published
observations demonstrating a biphasic effect of Dex on PB
induction [25]. mEH levels appeared only marginally
impacted by the additions of Dex.
Since the nuclear receptors CAR and RXRa are integral
to the PB induction response, we also examined their
respective mRNA levels under the specified culture con-
ditions. Altering Dex concentration was without substantive
effect on CAR mRNA expression level; however, RXRa
mRNA levels were clearly increased in the presence of z25
nM Dex.
While examining the expression character of several
liver-specific genes (Fig. 1D), we observed that albumin
mRNA levels were not adversely impacted by the absence
of Dex. However, transthyretin and transferrin levels were
clearly reduced under the same conditions, with transferrin
exhibiting the most sensitivity to Dex manipulation. Dex
omission resulted in substantial up-regulation of GST-Pi
mRNA expression, a response that was reverted to the
normal quiescent level in the presence of z5 nM Dex.
Dex rescue of hepatic gene expression
We tested whether the aberrant hepatic responses char-
acterized under Dex deficiency were reversible. The results
of these ‘Dex-rescue’ experiments are presented in Fig. 2.I n
most cases, additions of Dex to cells that had been deprived
of the hormone for 4, 24, or 48 h were effective in restoring
robust levels of hepatic responsiveness to PB (Fig. 2A) as
well as albumin, transthyretin, and transferrin expression
(Fig. 2B). Interestingly, PB induction responses could no
longer be restored in cells that were deprived of Dex for 72
h, despite restoration of the other more classical markers of
hepatic expression. These results imply that PB responsive-
ness is a uniquely sensitive indicator of hepatocyte differ-
entiation status.
Effects of Dex and ECM overlay on hepatocyte morphology
and cell viability
We assessed the impact of Dex modulation and ECM
addition on cultured hepatocytes using cell morphology
and viability endpoints. Either Dex omission or the
absence of ECM overlay resulted in a marked perturbation
of cell morphology from that typically associated with
differentiated hepatocytes in primary culture. The repre-
sentative photomicrographs, shown in Figs. 3A and B,
demonstrate that limiting conditions of Dex and/or ECM
omission disrupted typical cuboidal networks and bile
canalicular structures. Morphological deterioration was
clearly evident at Dex concentrations V5 nM, with cells
exhibiting condensed cytoplasm, abnormal rounding of
cell structure, and formation of fibroblast-like protrusions
(Fig. 3). Less LDH leakage (Fig. 3 insets) was apparent at
higher Dex concentrations (25–1000 nM). The presence
of ECM protected the cells, as morphological disruption
and LDH leakage was evident in ECM-treated cells only
when Dex was entirely omitted (Fig. 3A versus 3B).I n
Fig. 5. Effect of ECM overlay and dexamethasone concentration on the activation of stress signaling pathways in primary rat hepatocytes. Primary rat
hepatocytes were cultured for 96 h under variable concentrations of Dex and in the presence (+ECM) or absence (ECM) of an ECM overlay. Total cell
extracts were prepared as stated in Materials and methods and analyzed by Western blot analysis. Phosphospecific antibodies were used to discern the
phosphorylation status of p42/44 MAPK (Thr202/Tyr204), SAPK/JNK (Thr183/Tyr185), c-Jun (Ser63), and Akt (Ser473). The levels of immunoreactive
proteins also were assessed with phosphorylation-independent antibodies; a-MAPK is shown.
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of 1–5 nM were sufficient to maintain the formation of
intact networks with tight junctions and bile canalicular
structures (Fig. 3B).
Dex rescues hepatocyte morphology and cell fidelity
To determine if the perturbations in cell morphology
produced by Dex omission were reversible, we conducted a
time course experiment. In a similar scheme to that de-
scribed for Fig. 2, 25 nM Dex was added back to cells that
had been deprived of the hormone for varying periods. As
shown in Fig. 4, the complete omission of Dex resulted in
markedly compromised hepatocyte morphology and en-
hanced cytotoxicity, as evidenced by LDH leakage. The
morphological deterioration was not triggered until z72
h post-isolation, as noted by a decline in the fidelity of
cellular structure. These results paralleled the gene expres-
sion indices examined in the studies described in Fig. 2.
Dex and ECM modulate the auto-phosphorylation of
mitogenic and stress-inducible signaling pathways
In a previous study [30], we demonstrated that primary
hepatocytes and their inherent signaling pathways are
uniquely sensitive to chemical stress. Here, we hypothe-
sized that the compromised differentiation status of hep-
atocytes produced by the absence of Dex, denoted by
perturbation of hepatocyte morphology, reduction in cellu-
lar viability, and altered responsiveness marker genes, was
associated with a stress-related cytotoxic response. Cell
extracts were prepared from hepatocytes cultured for a total
of 96 h under varying Dex concentrations and ECM
environments. Western immunoblot analysis and phospho-
specific antibodies were used to assess the phosphorylation
status of several key signaling proteins involved in trans-
ducing the stress response.
Cells cultured in the absence of Dex exhibited a
marked stimulation of p42/44 MAPK, SAPK/JNK, and
c-Jun phosphorylation (Fig. 5). The presence of ECM
attenuated the activation of these pathways, even at the
1 nM Dex dose. The stress activation responses were
blunted completely with 5 nM Dex. In contrast, cells
cultured in the absence of an ECM overlay exhibited
stress pathway activation responses that could only be
attenuated modestly by Dex, even at the highest concen-
trations of Dex tested. Thus, there is an apparent synergy
between the effects of ECM and Dex in providing
attenuation of the stress cascades. No alterations of the
p38 MAPK pathway were observed under these same
conditions (data not shown). As depicted in Fig. 5 for
immunoreactive MAPK, the non-phosphorylated state of
SAPK/JNK, MAPK, and Akt were also determined with
control antibodies and the respective levels of these
proteins were unchanged across the Dex treatment con-
ditions (data not shown). The results presented in Fig. 5
using phosphospecific antibodies were confirmed in sepa-
rate assays by measuring functional activities associated
with each respective pathway (data not shown). It is
interesting to note that omission of Dex or ECM only
had minimal impact on the phosphorylation status of PKB,
a critical and positive effecter of cell survival and death
(Fig. 5). This latter result suggests that the cell survival
stimulus associated with Dex is independent of a PI3-
kinase pathway.
Dex stabilizes the DNA binding activity of liver-specific
transcription factors and suppresses the AP-1 associated
stress pathway
Since cell-specific transcription factors are clearly impor-
tant determinants of cellular differentiation, we asked wheth-
er the activated stress responses occurring in the absence of
Dex were associated with altered DNA binding activities of
specific nuclear transcription factors. As in our previous
experiments, cells were cultured for 96 h either in the
Fig. 6. EMSA analysis examining Dex-mediated stimulation of DNA
binding of liver-specific transcription factors and suppression of AP-1
complex in primary rat hepatocytes. Primary rat hepatocytes were cultured
for 96 h in the presence of an ECM overlay and under varying
concentrations of Dex (nM). Total nuclear protein was extracted as stated
in Materials and methods and 10 Ag of nuclear protein was incubated with
double-stranded oligonucleotides to AP-1, C/EBPa, HNF-1a,- 3 a,- 4 a, and
RXRa, as described in Materials and methods.
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trations of Dex (0, 1, 5, 25, 1000 nM). Nuclear extracts were
subsequently prepared and subjected to EMSA analysis
using double-stranded oligonucleotide probes encompassing
consensus-binding sites for AP-1, C/EBPa, HNF-1a,- 3 a,
-4a, and RXRa. The results of these studies are presented in
Fig. 6. Dex omissions resulted in a potent stimulation of AP-
1 binding. The magnitude of this aberrant response was
attenuated by gradually increasing the concentration of Dex
such that the complex was inhibited at Dex concentrations
z5 nM. These results correlated well with the marked
attenuation of the SAPK/JNK and c-Jun signaling pathways
observed under the same culture conditions (Fig. 5).
Concomitant with the increase in binding of the stress-
associated AP-1 complex, Dex omission markedly reduced
the DNA binding activities associated with several other
liver transcription factors. In absence of Dex, the cells
exhibited a marked reduction in the binding of C/EBPa,
HNF-1a, and RXRa, while the interaction of HNF-3a and
-4a to their respective DNA targets was completely extin-
guished (Fig. 6). Competition studies with excess unlabelled
oligonucleotides and with mutated probes were performed
to verify the specificity of the interactions (data not shown).
Dex rescues hepatocytes from intracellular stress
The capacity of Dex to rescue the respective transcrip-
tion factor DNA binding activities and stress-activation
responses was evaluated. Dex omission resulted in the
marked stimulation of the phosphorylation status of the
MAPK, SAPK/JNK, and c-Jun signaling pathways (Fig.
7A). Delayed additions of Dex (4, 24, 48, or 72 h post-
isolation) successfully attenuated the activation of these
responses. Consistent with the activation of these stress
pathways, limiting Dex conditions also triggered en-
hanced nuclear accumulation of the AP-1 complex (Fig.
7B). Reintroduction of Dex back to the culture environ-
ment, even at 48–72 h post-plating, largely restored the
levels of AP-1, C/EBPa, HNF-1a,- 3 a,- 4 a, and RXRa,
as assessed with EMSA experiments. Cells that were
maintained in the absence of an ECM overlay required
substantially higher concentrations of Dex (25–1000 nM)
to restore levels of transcription factor binding (data not
shown).
Effect of Dex dose and time course on the rescue of liver-
specific transcription factor expression
Finally, we sought to determine whether the reduction in
DNA binding activities, previously noted for the hepatic
transcription factors under conditions of reduced Dex, was
attributed directly to lowered levels of their respective
proteins. Nuclear extracts were prepared at several time
points in the absence or presence of 25 nM Dex and
assessed by Western immunoblot analysis using specific
antibodies. Dex omissions resulted in the marked reduction
Fig. 7. Dex rescues hepatocytes from stress-associated signaling pathways. Primary rat hepatocytes were cultured for 96 h in the presence of an ECM overlay.
At the indicated times (4, 24, 48, or 72 h post-plating), Dex (25 nM) was added to the medium and continued in the cultures until the 96-h time point. The
delayed effect of Dex addition on stress-associated signaling pathways (Panel A, phosphorylation signals) and EMSA analysis (Panel B) of DNA binding
activities associated with AP-1, AP-1, C/EBPa, HNF-1a,- 3 a,- 4 a and RXRa are shown.
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assessed (Fig. 8). As was the case in the previous experi-
ments, subsequent Dex additions were capable of largely
restoring the respective binding activities to levels consis-
tent with those observed in freshly isolated hepatocytes
(data not shown).
Discussion
Defined culture systems of primary hepatocytes provide
a unique resource for study of the underlying biology of
the liver parenchyma. Recent progress in the maintenance
of cultures of primary rodent and human hepatocytes has
enabled more detailed analysis of extracellular influences
involved in liver differentiation, growth, and survival
[32–34].
Cell–ECM interactions are critical in maintaining hepa-
tocyte differentiation via the establishment of cell polarity,
polygonal shape, and formation of bile canaliculi and
junctional complexes. These effects are mediated through
integrins [32,35,36], a family of transmembrane receptors,
which in turn cross-talk with components of the cytoskel-
eton. ECM-associated modulation of cell shape appears to
be inversely correlated with the control of gene expression.
Additionally, it has been proposed that tissue phenotype
depends on reciprocal interactions between the ECM and
structural organization of the nucleus [37]. A number of
studies have reported a correlation between ECM-induced
hepatocyte differentiation and the expression or function of
various liver-enriched transcription factors [38,39].F o r
example, the expression of HNF-3a and -4a appear to be
induced and stabilized by Dex treatment [40,41].
Using a well-defined rat hepatocyte system, we previ-
ously established that robust, in vivo-like responsiveness to
the prototypical hepatic inducer, PB, required the presence
of dilute concentrations of ECM [24]. Subsequently, we also
demonstrated that nanomolar additions of the synthetic
glucocorticoid, Dex, were essential to sustain maximal
levels of these induction responses [25,26], effects that have
been corroborated by other investigators [27].
To better identify mechanisms associated with these
responses that impact hepatocyte integrity, differentiation
status, and xenobiotic responsiveness, in the current work
we targeted specific cellular pathways for further analysis,
pathways we hypothesized as potential mediators of the
effects exerted by ECM and Dex. We examined the involve-
ment of several stress-associated pathways, including the
MAPK, SAPK/JNK, and c-Jun signaling pathways, and
resulting nuclear recruitment of the AP-1 complex. In
addition, we asked whether Dex and ECM might facilitate
hepatocyte differentiation and homeostasis by altering func-
tional expression of key liver-specific transcription factors.
Our results demonstrate the critical requirement for
defined additions of both nanomolar concentrations of
Dex and dilute additions of ECM in facilitating the main-
tenance of the differentiated liver phenotype in vitro. The
results also confirm a paradoxical effect exhibited with
highly elevated concentrations (z1 AM) of Dex whereby
PB-inducible CYP2B1/2 expression responses are attenuat-
ed. The latter responses were not associated with diminished
DNA binding or altered expression levels of any of the
transcription factors examined, nor did they result from any
visible alteration of hepatocyte morphology or differentia-
tion state. The mechanism through which high doses of Dex
suppress the PB induction may reside in cross-talk with
other nuclear receptors, such as PXR and remain to be
further elucidated.
Our data demonstrate the requirement of Dex in the
maintenance of the expression and respective DNA binding
activities for the liver-enriched transcription factors, C/
EBPa,- h,- g, HNF-1a,- 1 h,- 3 a,- 4 a, and RXRa. Recently,
other investigators reported that reintroduction of the liver-
specific transcription factor, HNF-4a, reinstated a differen-
tiated phenotype [42] and classical parenchymal morpholo-
gy [43] in de-differentiated hepatoma cells via restoration of
E-cadherin expression and concomitant responsiveness to
glucocorticoids, such as Dex. Using gene disruption techni-
ques, Li et al. [44] have demonstrated that HNF-4a repre-
sents a master regulator of hepatic differentiation; without it,
hepatocytes lose a broad spectrum of liver-specific func-
tions. Thus, as reported here, in the absence of Dex, the
down-regulation of HNF-4a function, together with other
liver-specific transcription factor interactions, likely contrib-
utes to the loss of hepatocyte differentiation features
assessed with our experimental endpoints.
Results of our investigations demonstrated that culture
medium additions of an ECM overlay, and particularly of
Dex, to deficient cultures produced rather spectacular res-
Fig. 8. Immunoblot determination of time course and dose effects of Dex
rescue on the expression levels of liver-specific transcription factors in
primary rat hepatocytes. See legend to Fig. 7 for details of experimental
treatments.
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teristics associated normally with the adult liver [25,35,45].
Nanomolar concentrations of Dex similarly sustained hepa-
tocyte viability, as manifested by a marked reduction in the
extracellular leakage of LDH. Combined, these observations
provide compelling evidence for the importance of Dex and
ECM in the maintenance of hepatocyte physiology.
Recent reports have proposed that both GCs [46,47] and
ECM [48,49] induce G1 growth arrest and subsequent
blockage of S phase progression, through suppression of
cyclins A and D1 and concomitant induction of cyclin-
dependent kinase (CDK) inhibitors p21
Waf1/Cip1 and p27
kip1
[50]. Similarly, GC-mediated cell cycle arrest triggered by
p21 induction in rat hepatoma cells requires the concomitant
steroid induction of C/EBPa [48,51], and ECM-mediated
induction of p21
Waf1/Cip1 results in increased p53 phosphor-
ylation [50,52]. Hepatocytes in vivo are typically in a G1
cell cycle-arrested state, consistent then with predicted
effects of Dex and ECM influence. The dramatic activation
of auto-phosphorylation of the Erk1/2 MAPK pathway in
primary hepatocytes seen in our experiments in the absence
of either Dex or ECM would be anticipated to result in a
loss of control of the signaling machinery regulating cell
cycle progression and mitogen-activated growth. Thus, our
findings suggest that Dex and ECM function to block
proliferative signals both at the level of AP-1 activation
and cell cycle progression, thereby facilitating the expres-
sion of a differentiated cellular phenotype.
The differentiated phenotype of the hepatocyte clearly
includes robust expression of albumin, transferrin, trans-
thyretin, and the PB induction response, as seen in the
Dex- and ECM-treated panels in Fig. 1. The contributions
of Dex and ECM on hepatocyte differentiation status are
further demonstrated by the remarkable dose-dependent
suppression that Dex exerts on GST Pi expression, a gene
that is normally repressed in adult liver but activated by AP-1
in preneoplastic liver foci. It is noteworthy that neither
albumin, transthyretin, or transferrin mRNA expression—
prototypical markers of hepatocyte function—are not as
sensitive to Dex or ECM deficiency as the PB induction
response is itself.
A recent study indicated that Dex treatments augment the
levels of CAR mRNA [27] in human hepatocytes. In our
experiments, the potentiative effects of Dex, on the PB
induction process, on transcription factor expression, and in
attenuating the stress pathway endpoints examined, were
typically manifested with 1–5 nM Dex concentrations. Only
Dex concentrations z25 nM led to a modest elevation in
the level of detectable RXRa mRNA and protein, however,
CAR levels were not noticeably affected by this or any of
the Dex levels tested. These results support a broader role
for Dex (and ECM) in the facilitation of the PB induction
response, indicating that Dex and ECM coordinately or-
chestrate a cluster of additional signaling networks that act
independently of the nuclear receptors CAR and RXRa to
modulate xenobiotic responsiveness in the hepatocyte.
In the absence of Dex and any exogenous mitogenic
stimuli, we observed a remarkable auto-phosphorylation of
the SAPK/JNK and MAPK (Erk1/2) signaling pathways.
Resultant downstream nuclear effects of these perturbed
signaling pathways included the nuclear recruitment of both
AP-1 and NF-nB (NF-nB data not shown). These responses
were mitigated by the dose-dependent readditions of Dex
and,toalesserextent,byreintroductionofanECMoverlay.It
is interesting that neither the omission of Dex or ECM
impacted the phosphorylation status of p38 MAPK (data
not shown).
The aberrant intracellular stress response mounted by
hepatocytes in the face of either Dex or ECM omission is
likely of fundamental physiological relevance. By providing
the cells with a physiologically stable and structured envi-
ronment, ECM appears to facilitate the response of cells to
soluble ligands via stabilization of receptor-mediated sig-
naling pathways [5,6] and effects a balance between result-
ing phosphorylation–dephosphorylation events. The ECM
responses appear closely coupled with those facilitated by
the presence of physiological concentrations of GCs. Dis-
ruption at any tier of this cascade appears to result in the
activation of aberrant and sustained auto-phosphorylation
signals, such as those demonstrated in the stress pathway
analysis conducted in the present investigation.
Taken together, we have demonstrated that low concen-
trations of Dex and ECM provide critical cues to the
hepatocyte in culture, functioning to preserve expression
character of a variety of hepatic nuclear factors, including C/
EBPa,-h,-g, HNF-1a,- 1 h,- 4 a, and RXRa; facilitate the
expression of prototypical hepatic marker genes, including
albumin and transferrin; preserve hepatic morphology; pro-
vide attenuation of several stress signaling pathways includ-
ing that of MAPK, SAPK/JNK, c-Jun, and AP-1 activation;
attenuate the expression of GST-Pi; and enhance hepatocyte
viability as monitored through LDH release. We propose
that the resultant phenotypic stability that Dex and ECM
confer to the hepatocyte is critical for establishing the
fidelity of cellular response to xenobiotics, particularly to
the class of PB inducing agents.
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